Aurobindo receives USFDA nod for its facility at UNIT-VI

Aurobindo Pharma Ltd has announced that the US FDA has approved its API facility at Unit-VI to manufacture sterile ceftiofur sodium.

This facility is situated on a 15-acre land in Chitkul village, Patancheruvu mandal of Medak district.

Source : Equity Bulls

Keywords